Display options
Cite
Mille B, Ingen-Housz-Oro S, De Prost N, et al. High frequency of eosinophilia and viral reactivation in drug hypersensitivity in patients with severe acute respiratory syndrome coronavirus 2 infection. J Eur Acad Dermatol Venereol. 2021;doi: 10.1111/jdv.17885.
Mille, B., Ingen-Housz-Oro, S., De Prost, N., Voiriot, G., Soria, A., Tetart, F., Bernier, C., Morice, C., Staumont-Salle, D., Dezoteux, F. (2021). High frequency of eosinophilia and viral reactivation in drug hypersensitivity in patients with severe acute respiratory syndrome coronavirus 2 infection. Journal of the European Academy of Dermatology and Venereology : JEADV, . https://doi.org/10.1111/jdv.17885
Mille, B, et al. "High frequency of eosinophilia and viral reactivation in drug hypersensitivity in patients with severe acute respiratory syndrome coronavirus 2 infection." Journal of the European Academy of Dermatology and Venereology : JEADV vol. (2021). doi: https://doi.org/10.1111/jdv.17885
Mille B, Ingen-Housz-Oro S, De Prost N, Voiriot G, Soria A, Tetart F, Bernier C, Morice C, Staumont-Salle D, Dezoteux F. High frequency of eosinophilia and viral reactivation in drug hypersensitivity in patients with severe acute respiratory syndrome coronavirus 2 infection. J Eur Acad Dermatol Venereol. 2021 Dec 20; doi: 10.1111/jdv.17885. Epub 2021 Dec 20. PMID: 34927763.
Copy Download .nbib Format: NLM
Share it on

J Eur Acad Dermatol Venereol. 2021 Dec 20; doi: 10.1111/jdv.17885. Epub 2021 Dec 20.

High frequency of eosinophilia and viral reactivation in drug hypersensitivity in patients with severe acute respiratory syndrome coronavirus 2 infection.

Journal of the European Academy of Dermatology and Venereology : JEADV

B Mille, S Ingen-Housz-Oro, N De Prost, G Voiriot, A Soria, F Tetart, C Bernier, C Morice, D Staumont-Salle, F Dezoteux,

Affiliations

  1. CHU Lille, Service de Dermatologie, Lille, France.
  2. AP-HP, Hôpital Henri Mondor, Service de Dermatologie, Créteil, France.
  3. Univ. Paris Est Créteil, Epiderme, Créteil, France.
  4. AP-HP, Hôpital Henri Mondor, Service de Réanimation, Créteil, France.
  5. AP-HP, Hôpital Tenon, Sorbonne Université, Service de Médecine Intensive Réanimation, Paris, France.
  6. AP-HP, Hôpital Tenon, Service de Dermatologie et d'Allergologie, Paris HUEP, Paris, France.
  7. Centre d'immunologie et des Maladies Infectieuses - Paris (Cimi-Paris), INSERM U1135, Paris, France.
  8. CHU Rouen, Centre Erik Satie, Service de Dermatologie, Rouen, France.
  9. CHU Nantes, Service de Dermatologie, Nantes, France.
  10. CHU Caen, Service de Dermatologie, Caen, France.
  11. Univ. Lille, CHU Lille, INSERM 1286, INFINITE - Institute for Translational Research in Inflammation, Lille, France.

PMID: 34927763 DOI: 10.1111/jdv.17885

[No abstract available.]

References

  1. Gottlieb M, Long B. Dermatologic manifestations and complications of COVID-19. Am J Emerg Med 2020; 38: 1715-1721. - PubMed
  2. Descamps V, Ranger-Rogez S. DRESS syndrome. Joint Bone Spine 2014; 81: 15-21. - PubMed
  3. Dordal Culla MT, Herrera-Lasso Regás V, Martí-Garrido J, Rodríguez Cumplido D, Vázquez-Revuelta P, Lleonart BR. Treating COVID-19: review of drug hypersensitivity reactions. J Investig Allergol Clin Immunol 2020; 30: 385-399. - PubMed
  4. Mesli F, Dumont M, Soria A et al. Benralizumab: a potential tailored treatment for life-threatening DRESS in the COVID-19 era. J Allergy Clin Immunol Pract 2021; 9: 3529-3531.e1. - PubMed
  5. Tanni F, Akker E, Zaman MM, Figueroa N, Tharian B, Hupart KH. Eosinopenia and COVID-19. J Osteopath Med 2020; 120: 504-508. - PubMed
  6. Li X, Yin D, Yang Y et al. Eosinophil: a nonnegligible predictor in COVID-19 re-positive patients. Front Immunol 2021; 12: 2970. - PubMed
  7. Paolucci S, Cassaniti I, Novazzi F et al. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count. Int J Infect Dis 2021; 104: 315-319. - PubMed
  8. Picard D, Janela B, Descamps V et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med 2010; 2: 46-62. - PubMed
  9. Balconi SN, Lopes NT, Luzzatto L, Bonamigo RR. Detection of SARS-CoV-2 in a case of DRESS by sulfasalazine: could there be a relationship with clinical importance? Int J Dermatol 2021; 60: 125-126. - PubMed
  10. Mitamura Y, Schulz D, Oro S et al. Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID-19 patients. Allergy 2021; 1-14. - PubMed

Publication Types